These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


735 related items for PubMed ID: 31208261

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 3. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T, Ladrón de Guevara A, Codner E, Preisler J, Crisosto N, Echiburú B, Maliqueo M, Sánchez F, Perez-Bravo F, Cassorla F.
    Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
    [Abstract] [Full Text] [Related]

  • 4. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A, Yetim Ç, Baş F, Erol OB, Çığ G, Uçar A, Darendeliler F.
    J Clin Res Pediatr Endocrinol; 2016 Sep 01; 8(3):288-97. PubMed ID: 27125339
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
    Yue CY, Lu LK, Li M, Zhang QL, Ying CM.
    PLoS One; 2018 Sep 01; 13(8):e0203129. PubMed ID: 30153296
    [Abstract] [Full Text] [Related]

  • 7. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
    Asanidze E, Khristesashvili J, Pkhaladze L, Barbakadze L.
    Georgian Med News; 2018 Feb 01; (Issue):34-40. PubMed ID: 29578420
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul 01; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct 01; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

  • 16. Which hormone tests for the diagnosis of polycystic ovary syndrome?
    Robinson S, Rodin DA, Deacon A, Wheeler MJ, Clayton RN.
    Br J Obstet Gynaecol; 1992 Mar 01; 99(3):232-8. PubMed ID: 1296589
    [Abstract] [Full Text] [Related]

  • 17. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.
    Akush Ginekol (Sofiia); 2014 Mar 01; 53(5):22-7. PubMed ID: 25558667
    [Abstract] [Full Text] [Related]

  • 18. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M, Madej P, Owczarek A, Chudek J, Skałba P.
    Clin Endocrinol (Oxf); 2015 Jul 01; 83(1):98-104. PubMed ID: 25440474
    [Abstract] [Full Text] [Related]

  • 19. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y, Wei LN, Xiong YL, Liang XY.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug 01; 45(8):567-70. PubMed ID: 21029609
    [Abstract] [Full Text] [Related]

  • 20. Changes in serum markers of patients with PCOS during consecutive clomiphene stimulation cycles: a retrospective study.
    Hager M, Hörath S, Frigo P, Koch M, Marculescu R, Ott J.
    J Ovarian Res; 2019 Oct 04; 12(1):91. PubMed ID: 31585548
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.